City

Ann Arbor (1)

Rochester (1)

Condition

Melanoma, Mucosal (2)

Liver Metastases (1)

Melanoma (Skin) (1)

Melanoma Stage IV (1)

Melanoma, Cutaneous (1)

Melanoma, Ocular (1)

Melanoma, Uveal (1)

Metastatic Melanoma (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

University of Michigan Rogel Cancer Center (1)

Viewpoint Molecular Targeting (1)

Collaborator

Mayo Clinic (1)

Intervention

[203pb]vmt01 (1)

[68ga]vmt02 (1)

ipilimumab (1)

nivolumab (1)

stereotactic body radiation therapy (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

melanoma, mucosal

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal Trial in Rochester ([203Pb]VMT01, [68Ga]VMT02)

Recruiting

Melanoma (Skin)
+3 more

Rochester, Minnesota

Mayo Clinic

Aug 5, 2022

Melanoma, Ocular, Melanoma, Cutaneous, Metastatic Melanoma Trial in Ann Arbor (Ipilimumab, Nivolumab, Stereotactic Body

Not yet recruiting

Melanoma, Ocular
+4 more

Ipilimumab
+2 more

Ann Arbor, Michigan

University of Michigan Rogel Cancer Center

Mar 16, 2022